Drugs / Cicaderma
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04300829 | Jun 2020 → Sep 2022 | breast adenocarcinoma, radiodermatitis | Centre Leon Berard | Unknown | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cicaderma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04300829 ↗ |